Fighting breast cancer with a 1-2-3 punch

Seven's On Call with Dr. Jay Adlersberg
September 5, 2008 3:47:50 PM PDT
Marlene Hardy and Rosalind Bille-Pridmore are pioneers in the treatment of breast cancer. Pioneers because they're participating in a study to treat one of the least curable types of the disease.

"There really was not too much available once it travels from the breast to other parts of the body," Hardy said.

Both have what's called triple negative cancer. It has none of the three targets for the most common breast cancer drugs.

With a 1-2-3 punch of different medications, researchers are trying to wipe out this cancer with treatment geared to it specifically.

"Therapies that will work well in one kind of breast cancer will not work well in other kinds," Dr. Shridra Ganesan of the Cancer Institute of New Jersey said.

Doctors know how these cancer cells multiply and have chosen three drugs to specifically stop the cancer's growth.

One, avastin, works to strangle the cancer.

Avastin is one of the newest cancer fighters. It works by blocking the blood vessels that feed the cancer.

Triple negative cancers spread quickly, but even early tests in this patient are exciting to the researchers.

Women such as Marlene and Roz who have triple negative cancers, which have spread to other parts of the body, are eligible for this study, and doctors are looking for more volunteers.

You can contact the Cancer Institute of New Jersey about its triple negative cancer study at (732)235-7251.

Click here for more New York and Tri-State News

Report a typo || Email story ideas || Send news photos/videos